Vicuron Pharmaceuticals Inc.
🏢 View company profile →23Patents
4Active
23Granted
34Portfolio score
Filing activity: Feb 9, 1999 → Jun 2, 2009 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6797820B2 | Succinate compounds, compositions and methods of use and preparation | Chemistry; Metallurgy | 14 | Expired |
| US7198796B2 | Antifungal parenteral products | Human Necessities | 12 | Expired |
| US7199106B2 | Lincomycin derivatives possessing antimicrobial activity | Chemistry; Metallurgy | 7 | Expired |
| US6852752B2 | Urea compounds, compositions and methods of use and preparation | Chemistry; Metallurgy | 7 | Expired |
| US6987104B2 | Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use | Chemistry; Metallurgy | 6 | Expired |
| US7199105B2 | Lincomycin derivatives possessing antibacterial activity | Chemistry; Metallurgy | 5 | Expired |
| US8143212B2 | Dalbavancin compositions for treatment of bacterial infections | Emerging Cross-Sectional Technologies | 4 | Active |
| US7256177B2 | Lincomycin derivatives possessing antibacterial activity | Chemistry; Metallurgy | 4 | Expired |
| US7164011B2 | Lincomycin derivatives possessing antibacterial activity | Chemistry; Metallurgy | 4 | Expired |
| US7119061B2 | Dalbavancin compositions for treatment of bacterial infections | Human Necessities | 4 | Expired |
| US6900175B2 | Methods of administering dalbavancin for treatment of bacterial infections | Human Necessities | 2 | Expired |
| US6977141B2 | Direct adsorption scintillation assay for measuring enzyme activity and assaying biochemical processes | Physics | 2 | Expired |
| US7351687B2 | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof | Chemistry; Metallurgy | 2 | Expired |
| US7319088B2 | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof | Human Necessities | 2 | Expired |
| US6720305B1 | Injectable formulations containing ramoplanin | Human Necessities | 1 | Expired |
| US7115564B2 | Stable pharmaceutical compositions of dalbavancin and methods of administration | Human Necessities | 1 | Expired |
| US7407654B2 | Antibiotics GE 81112 factors A,B,B1, pharmaceutically acceptable salts and compositions, and use thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6991800B2 | Antifungal parenteral products | Human Necessities | 1 | Expired |
| US7169890B2 | Process for the production of ramoplanin-like amide derivatives | Chemistry; Metallurgy | 0 | Expired |
| US7615635B2 | N-formyl hydroxylamines | Chemistry; Metallurgy | 0 | Active |
| US7763751B2 | Hydroxylamine derivatives | Chemistry; Metallurgy | 0 | Expired |
| US8007789B2 | Antibiotics GE 81112 factors A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US7612059B2 | Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.